Phase 3 multicenter, open-label, randomized study of infigratinib versus gemcitabine plus cisplatin in the first-line treatment of patients with advanced cholangiocarcinoma with FGFR2 gene fusions/translocations: the PROOF trial
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) Konferenzschrift |
| Sprache: | Englisch |
| Veröffentlicht: |
2019
|
| In: |
Annals of oncology
Year: 2019, Jahrgang: 30, Pages: iv62 |
| ISSN: | 1569-8041 |
| DOI: | 10.1093/annonc/mdz155.224 |
| Online-Zugang: | Verlag, lizenzpflichtig: https://doi.org/10.1093/annonc/mdz155.224 Verlag, lizenzpflichtig: http://www.sciencedirect.com/science/article/pii/S0923753419307434 
|
| Verfasserangaben: | M Javle, I Borbath, S Clarke, E Hitre, C Louvet, T Macarulla, D Oh, J Spratlin, J Valle, K Weiss, C Berman, M Howland, Y Ye, T Cho, S Moran, G Abou-Alfa |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1703417984 | ||
| 003 | DE-627 | ||
| 005 | 20220818141619.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200703s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/annonc/mdz155.224 |2 doi | |
| 035 | |a (DE-627)1703417984 | ||
| 035 | |a (DE-599)KXP1703417984 | ||
| 035 | |a (OCoLC)1341342164 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Javle, Milind |e VerfasserIn |0 (DE-588)1205686363 |0 (DE-627)1691312991 |4 aut | |
| 245 | 1 | 0 | |a Phase 3 multicenter, open-label, randomized study of infigratinib versus gemcitabine plus cisplatin in the first-line treatment of patients with advanced cholangiocarcinoma with FGFR2 gene fusions/translocations |b the PROOF trial |c M Javle, I Borbath, S Clarke, E Hitre, C Louvet, T Macarulla, D Oh, J Spratlin, J Valle, K Weiss, C Berman, M Howland, Y Ye, T Cho, S Moran, G Abou-Alfa |
| 264 | 1 | |c 2019 | |
| 300 | |a 1 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Poster | ||
| 500 | |a Conference abstract P-225 | ||
| 500 | |a Gesehen am 03.07.2020 | ||
| 700 | 1 | |a Borbath, I. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Clarke, S. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hitre, E. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Louvet, C. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Macarulla, T. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Oh, D. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Spratlin, J. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Valle, J. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Weiss, Karl Heinz |d 1976- |e VerfasserIn |0 (DE-588)130069531 |0 (DE-627)489615465 |0 (DE-576)297980203 |4 aut | |
| 700 | 1 | |a Berman, C. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Howland, M. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ye, Y. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Cho, T. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Moran, S. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Abou-Alfa, G. |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of oncology |d Amsterdam [u.a.] : Elsevier, 1990 |g 30(2019), Supplement 4, Seite iv62 |h Online-Ressource |w (DE-627)320428796 |w (DE-600)2003498-2 |w (DE-576)098134345 |x 1569-8041 |7 nnas |a Phase 3 multicenter, open-label, randomized study of infigratinib versus gemcitabine plus cisplatin in the first-line treatment of patients with advanced cholangiocarcinoma with FGFR2 gene fusions/translocations the PROOF trial |
| 773 | 1 | 8 | |g volume:30 |g year:2019 |g supplement:Supplement 4 |g pages:iv62 |g extent:1 |a Phase 3 multicenter, open-label, randomized study of infigratinib versus gemcitabine plus cisplatin in the first-line treatment of patients with advanced cholangiocarcinoma with FGFR2 gene fusions/translocations the PROOF trial |
| 856 | 4 | 0 | |u https://doi.org/10.1093/annonc/mdz155.224 |x Verlag |x Resolving-System |z lizenzpflichtig |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S0923753419307434 |x Verlag |z lizenzpflichtig |
| 951 | |a AR | ||
| 992 | |a 20200703 | ||
| 993 | |a ConferencePaper | ||
| 994 | |a 2019 | ||
| 998 | |g 130069531 |a Weiss, Karl Heinz |m 130069531:Weiss, Karl Heinz |d 910000 |d 910100 |e 910000PW130069531 |e 910100PW130069531 |k 0/910000/ |k 1/910000/910100/ |p 10 | ||
| 999 | |a KXP-PPN1703417984 |e 3695148209 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"display":"Javle, Milind","given":"Milind","family":"Javle","roleDisplay":"VerfasserIn","role":"aut"},{"display":"Borbath, I.","given":"I.","family":"Borbath","roleDisplay":"VerfasserIn","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Clarke, S.","family":"Clarke","given":"S."},{"display":"Hitre, E.","family":"Hitre","given":"E.","role":"aut","roleDisplay":"VerfasserIn"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Louvet, C.","family":"Louvet","given":"C."},{"display":"Macarulla, T.","given":"T.","family":"Macarulla","role":"aut","roleDisplay":"VerfasserIn"},{"role":"aut","roleDisplay":"VerfasserIn","family":"Oh","given":"D.","display":"Oh, D."},{"display":"Spratlin, J.","family":"Spratlin","given":"J.","roleDisplay":"VerfasserIn","role":"aut"},{"display":"Valle, J.","family":"Valle","given":"J.","roleDisplay":"VerfasserIn","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","family":"Weiss","given":"Karl Heinz","display":"Weiss, Karl Heinz"},{"roleDisplay":"VerfasserIn","role":"aut","display":"Berman, C.","family":"Berman","given":"C."},{"given":"M.","family":"Howland","display":"Howland, M.","role":"aut","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","role":"aut","display":"Ye, Y.","given":"Y.","family":"Ye"},{"roleDisplay":"VerfasserIn","role":"aut","display":"Cho, T.","given":"T.","family":"Cho"},{"roleDisplay":"VerfasserIn","role":"aut","family":"Moran","given":"S.","display":"Moran, S."},{"given":"G.","family":"Abou-Alfa","display":"Abou-Alfa, G.","role":"aut","roleDisplay":"VerfasserIn"}],"name":{"displayForm":["M Javle, I Borbath, S Clarke, E Hitre, C Louvet, T Macarulla, D Oh, J Spratlin, J Valle, K Weiss, C Berman, M Howland, Y Ye, T Cho, S Moran, G Abou-Alfa"]},"physDesc":[{"extent":"1 S."}],"note":["Poster","Conference abstract P-225","Gesehen am 03.07.2020"],"recId":"1703417984","title":[{"title":"Phase 3 multicenter, open-label, randomized study of infigratinib versus gemcitabine plus cisplatin in the first-line treatment of patients with advanced cholangiocarcinoma with FGFR2 gene fusions/translocations","subtitle":"the PROOF trial","title_sort":"Phase 3 multicenter, open-label, randomized study of infigratinib versus gemcitabine plus cisplatin in the first-line treatment of patients with advanced cholangiocarcinoma with FGFR2 gene fusions/translocations"}],"language":["eng"],"id":{"doi":["10.1093/annonc/mdz155.224"],"eki":["1703417984"]},"relHost":[{"origin":[{"dateIssuedDisp":"1990-","publisherPlace":"Amsterdam [u.a.] ; Dordrecht [u.a.] ; Oxford","dateIssuedKey":"1990","publisher":"Elsevier ; Kluwer ; Oxford Univ. Press"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"id":{"zdb":["2003498-2"],"issn":["1569-8041"],"eki":["320428796"]},"part":{"volume":"30","extent":"1","pages":"iv62","year":"2019","text":"30(2019), Supplement 4, Seite iv62"},"pubHistory":["1.1990 -"],"disp":"Phase 3 multicenter, open-label, randomized study of infigratinib versus gemcitabine plus cisplatin in the first-line treatment of patients with advanced cholangiocarcinoma with FGFR2 gene fusions/translocations the PROOF trialAnnals of oncology","physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"title":[{"subtitle":"official journal of the European Society for Medical Oncology","title_sort":"Annals of oncology","title":"Annals of oncology"}],"recId":"320428796","corporate":[{"role":"isb","roleDisplay":"Herausgebendes Organ","display":"European Society for Medical Oncology"}],"note":["Gesehen am 12.11.20","Ungezählte Beil.: Supplement"]}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedDisp":"2019","dateIssuedKey":"2019"}]} | ||
| SRT | |a JAVLEMILINPHASE3MULT2019 | ||